What is a next generation sequencing technique and what is a NGS platform.
What is next generation sequencing: and the different techniques and platforms that are available
-
Last edited by brc458; 06-15-2011, 12:34 PM. -
Try starting here. Let me know if you cant get the full article and I will send you a copy. -
Shurjo,
Thank you. But what does it mean by techniques? Is that the same as platforms? Or does it refer to transcriptome, exome whole genome sequencing? The two terms are confusing me. I've written about the 458 and illumina so am assuming that i've written about "platforms" but what does it mean by techniques?Comment
-
I'd guess you've guessed right on techniques; experimental paradigms would have been the fancier & perhaps less ambiguous way to state it.Comment
-
Each "platform" (Illumina/Solid/454/PacBio) can be used for multiple "techniques" (whole-genome/exome/transcriptome/ChipSeq/custom application). An analogous word sometimes used for "platform" is "chemistry".Originally posted by brc458 View PostComment
-
I'm an undergrad who is just beginning to explore bioiformatics. I tried the link above and I couldn't access the full text. Any chance you could email me a copy? Many thanks shurjo!Originally posted by shurjo View PostComment
-
-
I am new to this forum and as well a new fellow just trying to gain a PhD, my first task is to analyse a deep sequencing (Illumina) data from RNA of apple. how do i start? what should i do?Comment
-
Depends on your project and source of the RNA. Since it is RNA I am presuming you are doing a transcriptome project. Furthermore I am going to presume that you are looking for de-novo transcripts (as versus RNA-seq counts.) I do not know the state of the Apple annotation but, presuming that it is non-existent, then doing a cDNA assembly followed by an annotation program such as Blast2Go would be a good first start.
But I could be way off-base on the goals of your project. Why don't you describe it more fully and then people may be able to give you more concrete advice. To put this in other terms, basically what you asked us is akin to saying "I am visiting Rome; what should I do and where should I stay?" The answer is "it depends" -- unless we know more about what you want to accomplish.Comment
-
I can't read the article recommended by shurjo neither. Can someone / you send me a copy also ? thx
cameiComment
-
attached is the article that was requestedComment
-
thank you very muchComment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment